维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="PALADINO JA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	What have we learned from pharmacokinetie and pharmacodynamic theories? 显示文摘	SCHENTAG JJ GILLILAND KK PALADINO JA	2001	Clin Infect Dis2001，32，1：	1
2	Cost effectiveness of ivtooralswitch therapy : azithromycin vs cofuroxime with or without ery-thromycin for the treatment of community acquired pnenmonial 显示文摘	Paladino JA Gudgel LD Forrest A	2012	Chest2012，122，4：	1
3	Cefepime: a fourth-generation parenteral cephalosporin显示文摘	Wynd MA Paladino JA	1996	Ann Pharmacother1996，30，12：	1
4	Pharmacoecomics of antimicrobial therapy 显示文摘	Paladino JA	1999	Am J Health-Syst Pharm1999，56，223：	1
5	Comparison of fluoroquinolones based on pharmakinetic and pharmocodynamic parameters显示文摘	Pickerill KE Paladino JA Schentag JJ	2000	Pharmatherapy2000，20，4：	1
6	What have we learned from pharmacokinetic and pharmacodynamic theories显示文摘	Schentag JJ Gilliland KK Paladino JA	2001	Clin Infect Dis2001，32，1：	1
7	Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘	McKinnon PS Paladino JA Schentag JJ	2008	Int J Antimicrob Agents2008，31，4：	1
8	Linezolid: An oxazolidinone antimi- crobial agent显示文摘	Paladino JA	2002	Am J Health Syst Pharm2002，59，24：	1
9	Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘	Dresser LD Niederman MS Paladino JA	2001	Chest2001，119，5：	1
10	Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘	McKinnon PS Paladino JA Schentag JJ	2008	Int J Antimicrob Agents2008，31，4：	1
11	Cost-effectiveness comparison of cefepime and ceftazidime usingdecision analysis显示文摘	Paladino JA	1994	Pharmacoeconomics1994，5，：	1
12	Evaluation of area under the inhibitory curve ( AUIC ) and time above the minimum inhibitory concentration ( T>MIC ) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘	MCKINNON PS PALADINO JA SCHENTAG JJ	2008	Int J Antimicrob Agents2008，31，4：	1
13	Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘	Dresser LD Niedeman MS Paladino JA	2001	Chest2001，119，5：	1
14	Cost effectiveness of ivtooral switch therapy:Azithromycin vsCefuroximewith orwithout Erythromycin for the treatment of com unity-acquired pneumonia显示文摘	Paladino JA Gudgel LD Forrest A	2002	Chest2002，122，4：	1
15	Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics 显示文摘	Paladino JA Sperry HE Backes JM	1991	Am J Med1991，91，：	1
16	Cost ef-fectiveness of iv-to-oral switch therapy:a zithr om ycin vs co-furoxime with or without erythromycin for the treatment ofcommunity acquired pnenmonia显示文摘	PALADINO JA GUDGEL LD FORREST A	2002	Chest2002，122，4：	1
17	Economic justification of antimicrobial management programs: implications of antimicrobial resistance 显示文摘	Paladino JA	2000	Am J Health Syst Pharm2000，57，2：	1
18	Cost effectiveness of iv-to-oral switch therapy:Azithromycin vs Cofuroxime with or without Erythromycin for the treatment of community acquired pnenmonia显示文摘	Paladino JA Gudgel LD Forrest A	2002	Chest2002，122，4：	1
19	Evaluation of area under the inhibitory curve (AUIC) and time above the mini mum inhibitory concentration (T> MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial in feetions显示文摘	McKinnon PS Paladino JA Schentag JJ	2008	Int J Antimicrob Agents2008，31，4：	1
20	Cost-effectiveness of gatifloxacin vs ceftraxone with a macrolide for the treatment of community-acquired pneumonia显示文摘	Dresser LD Niederman MS Paladino JA	2001	Chest2001，119，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示